InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Litchfield Caroline, Chief Financial Officer. Insider active across 1 companies, notably Merck & Co., Inc.. Cumulatively, 9 reports have been logged. The latest transaction was filed on 3 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
€64,352773 shares@ €83.250.0000% mcap13.9% of flow
Common Stock
SEC:0001127602-22-013286:0·
€72,898866 shares@ €84.17830.0000% mcap15.7% of flow
Common Stock
SEC:0001127602-22-013030:0·
€157,9342,429 shares@ €65.02030.0001% mcap34.0% of flow
Common Stock
SEC:0001127602-22-007023:0·
022,683 shares0
Common Stock
SEC:0001127602-21-028467·
022,683 shares0
Common Stock
SEC:0001127602-21-028467:0·
1,039 shares
Common Stock
SEC:0001127602-21-015766·
€65,7041,039 shares@ €63.23740.0000% mcap14.2% of flow
Common Stock
SEC:0001127602-21-015766:0·
€51,603840 shares@ €61.43270.0000% mcap11.1% of flow
Common Stock
SEC:0001127602-21-015269:0·
€51,603840 shares@ €61.43270.0000% mcap100.0% of flow
Common Stock
SEC:0001127602-21-015269·
9 of 9 declarations
About Litchfield Caroline
Caroline Litchfield is the Chief Financial Officer (CFO) and Executive Vice President at Merck & Co., Inc. She is responsible for the company's financial management, including financial planning, risk management, and financial reporting. With strong expertise in finance and corporate strategy, Litchfield plays a critical role in making strategic financial decisions that support Merck's mission. Her leadership contributes to the financial performance and sustainability of the company.
